Home » Stocks » Electromed

Electromed, Inc. (ELMD)

Stock Price: $17.50 USD -0.57 (-3.13%)
Updated Aug 6, 2020 10:54 AM EDT - Market open

Stock Price Chart

Key Info

Market Cap 148.42M
Revenue (ttm) 34.20M
Net Income (ttm) 3.94M
Shares Out 8.48M
EPS (ttm) 0.46
PE Ratio 38.03
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 6, 2020
Last Price $17.50
Previous Close $18.06
Change ($) -0.57
Change (%) -3.13%
Day's Open 17.91
Day's Range 17.44 - 18.16
Day's Volume 20,891
52-Week Range 5.17 - 19.73

More Stats

Market Cap 148.42M
Enterprise Value 138.49M
Earnings Date (est) Sep 29, 2020
Ex-Dividend Date n/a
Shares Outstanding 8.48M
Float 6.46M
EPS (basic) 0.47
EPS (diluted) 0.46
FCF / Share 0.29
Dividend n/a
Dividend Yield n/a
Earnings Yield 2.63%
FCF Yield 1.65%
Payout Ratio n/a
Shares Short 361,592
Short Ratio 2.10
Short % of Float 5.24%
Beta 0.44
PE Ratio 38.03
Forward PE n/a
P/FCF Ratio 60.68
PS Ratio 4.34
PB Ratio 5.09
Revenue 34.20M
Operating Income 5.31M
Net Income 3.94M
Free Cash Flow 2.45M
Net Cash 9.93M
Net Cash / Share 1.17
Gross Margin 69.74%
Operating Margin 15.54%
Profit Margin 11.50%
FCF Margin 7.15%
ROA 11.25%
ROE 14.62%
ROIC 30.10%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$19.00*
Low
19.0
Current: $17.50
High
19.0
Target: 19.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue31.3028.3125.8622.9919.4115.4915.1019.5219.0014.30
Revenue Growth10.57%9.46%12.48%18.46%25.31%2.54%-22.64%2.74%32.86%-
Gross Profit23.8521.7720.5717.8813.6010.6310.4514.1513.7810.38
Operating Income2.822.713.573.111.31-0.74-1.830.611.871.80
Net Income1.971.832.232.211.09-1.29-1.330.191.060.92
Shares Outstanding8.318.218.178.148.128.118.118.117.826.08
Earnings Per Share0.230.210.260.270.13-0.16-0.160.020.130.15
EPS Growth9.52%-19.23%-3.7%107.69%----84.62%-13.33%-
Operating Cash Flow2.592.441.192.172.782.071.88-1.17-1.420.61
Capital Expenditures-1.33-0.53-0.62-0.53-0.52-0.90-1.02-0.79-0.45-0.27
Free Cash Flow1.261.920.571.632.261.170.86-1.96-1.870.34
Cash & Equivalents7.817.465.575.123.601.500.501.704.090.61
Total Debt-1.101.151.191.251.301.393.413.794.20
Net Cash / Debt7.816.354.433.932.350.21-0.89-1.710.30-3.59
Assets29.4027.3923.0620.5817.4115.7917.5620.9220.8714.14
Liabilities3.674.803.994.223.483.073.635.846.166.68
Book Value25.7322.5919.0716.3613.9212.7213.9315.0814.717.46
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Electromed, Inc.
Country United States
Employees 119
CEO Kathleen S. Skarvan

Stock Information

Ticker Symbol ELMD
Stock Exchange NYSE American
Sector Healthcare
Industry Medical Devices
Unique Identifier NYSEAMERICAN: ELMD
IPO Date August 13, 2010

Description

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation therapy in pulmonary care for patients of all ages in the United States and internationally. The company offers SmartVest airway clearance system that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to patients with compromised pulmonary function; and SmartVest SQL System that provides advanced generator programmability and an enhanced pause feature with save, lock, and restore functionality. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers working in intensive care units; and Aerobika, an oscillating positive expiratory pressure device. The company offers its products primarily to home health care market for patients with chronic lung issues, including bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was founded in 1992 and is headquartered in New Prague, Minnesota.